Shares of Moderna are popping in anticipation of it joining the S&P 500 on July 21 – and the analyst cited in today’s article believes the stock’s run is far from over. In fact, he declares Moderna “the Tesla of biotech” and sees at least two medium-term catalysts for its stock price. – CLICK HERE.
Is Moderna “The Tesla Of Biotech”?
- by RobH
